Literature DB >> 4991116

Allergic encephalomyelitis: immunologically specific inhibition of cellular passive transfer by encephalitogenic basic proteins.

S Levine, E M Hoenig, M W Kies.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4991116      PMCID： PMC1712791     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  26 in total

1.  ENCEPHALITOGEN-INDUCED INHIBITION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS: PREVENTION, SUPPRESSION AND THERAPY.

Authors:  E C ALVORD; C M SHAW; S HRUBY; M W KIES
Journal:  Ann N Y Acad Sci       Date:  1965-03-31       Impact factor: 5.691

2.  Specificity of encephalitogen-induced inhibition of experimental "allergic" encephalomyelitis in the guinea pig.

Authors:  C M SHAW; E C ALVORD; W J FAHLBERG; M W KIES
Journal:  J Immunol       Date:  1962-07       Impact factor: 5.422

3.  Factors affecting the suppression of allergic encephalomvelitis by homologous brain protein fractions.

Authors:  M W KIES; C M SHAW; W J FAHLBERG; E C ALVORD
Journal:  Ann Allergy       Date:  1960-08

4.  Passive transfer of the delayed dermal sensitivity to tuberculin by means of blood leukocytes.

Authors:  A OLIVEIRA-LIMA
Journal:  Am Rev Tuberc       Date:  1958-09

5.  Desensitization in vitro--the specific inhibition, by antigen, of the passive transfer of delayed hypersensitivity by peritoneal exudate cells.

Authors:  G L Asherson; S H Stone
Journal:  Immunology       Date:  1967-11       Impact factor: 7.397

Review 6.  Delayed hypersensitivity and desensitization to chemical haptens: antigenic specificity of delayed hypersensitivity.

Authors:  P G Gell; R A Wolstencroft
Journal:  Br Med Bull       Date:  1967-01       Impact factor: 4.291

7.  Allergic encephalomyelitis: passive transfer prevented by encephalitogen.

Authors:  S Levine; E M Hoenig; M W Kies
Journal:  Science       Date:  1968-09-13       Impact factor: 47.728

8.  Immunological tolerance in vitro: kinetic studies at the cellular level.

Authors:  E Diener; W D Armstrong
Journal:  J Exp Med       Date:  1969-03-01       Impact factor: 14.307

9.  In vitro demonstration of cellular sensitivity in allergic encephalomyelitis.

Authors:  J R David; P Y Paterson
Journal:  J Exp Med       Date:  1965-12-01       Impact factor: 14.307

10.  Suppression of experimental "allergic" encephalomyelitis in guinea pigs by encephalitogenic proteins extracted from homologous brain.

Authors:  C M SHAW; W J FAHLBERG; M W KIES; E C ALVORD
Journal:  J Exp Med       Date:  1960-02-01       Impact factor: 14.307
View more
  9 in total

Review 1.  Hyperacute, neutrophilic, and localized forms of experimental allergic encephalomyelitis: a review.

Authors:  S Levine
Journal:  Acta Neuropathol       Date:  1974       Impact factor: 17.088

2.  Experimental allergic encephalomyelitis. Production by myelin basic protein adsorbed on particulate adjuvants.

Authors:  S Levine; R Sowinski; R Gruenewald; M W Kies
Journal:  Immunology       Date:  1972-10       Impact factor: 7.397

3.  Treatment of experimental allergic encephalomyelitis with myelin basic protein: which route is best?

Authors:  S Levine; R Sowinski
Journal:  Neurochem Res       Date:  1984-10       Impact factor: 3.996

4.  A new form of localized allergic encephalomyelitis featuring polymorphonuclear neutrophilic leukocytes.

Authors:  S Levine; E M Hoenig
Journal:  Am J Pathol       Date:  1971-07       Impact factor: 4.307

5.  Protection of rats from experimental allergic encephalomyelitis with antiserum to guinea-pig spinal cord.

Authors:  R A Hughes
Journal:  Immunology       Date:  1974-04       Impact factor: 7.397

6.  Hyperacute allergic encephalomyelitis. A localized form produced by passive transfer and pertussis vaccine.

Authors:  S Levine; R Sowinski
Journal:  Am J Pathol       Date:  1973-10       Impact factor: 4.307

7.  Successful immunization against experimental allergic encephalomyelitis with myelin basic protein-sensitized allogeneic lymphocytes.

Authors:  G A Hashim
Journal:  Neurochem Res       Date:  1981-06       Impact factor: 3.996

8.  Suppression and treatment of experimental allergic encephalitis in guinea-pigs with the bovine spinal cord protein (BSCP).

Authors:  C F MacPherson
Journal:  Immunology       Date:  1980-07       Impact factor: 7.397

9.  Immunopathogenesis of acute central nervous system disease produced by lymphocytic choriomeningitis virus. II. Adoptive immunization of virus carriers.

Authors:  D H Gilden; G A Cole; N Nathanson
Journal:  J Exp Med       Date:  1972-04-01       Impact factor: 14.307
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.